blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2283133

EP2283133 - COMPOSITIONS AND USE OF EPAS1 INHIBITORS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  01.05.2015
Database last updated on 25.09.2024
Most recent event   Tooltip01.05.2015Application deemed to be withdrawnpublished on 03.06.2015  [2015/23]
Applicant(s)For all designated states
Calando Pharmaceuticals, Inc.
225 South Lake Avenue
3rd Floor
Pasadena, CA 91101 / US
[2012/15]
Former [2011/07]For all designated states
Calando Pharmaceuticals, Inc.
129 N Hill Ave, Ste 104
Pasadena, CA 91106 / US
Inventor(s)01 / DAVIS, Mark, E.
575 Laguna Road
Pasadena CA 91105 / US
02 / HEIDEL, Jeremy, D.
260 Kensington Drive
Madison WI 53704 / US
03 / LIU, Joanna, Yi-Ching
6728 North Golden West Avenue
Arcadia CA 91007 / US
 [2011/07]
Representative(s)Graf von Stosch, Andreas, et al
Graf von Stosch
Patentanwaltsgesellschaft mbH
Prinzregentenstrasse 22
80538 München / DE
[N/P]
Former [2011/07]Graf von Stosch, Andreas, et al
Graf von Stosch Patentanwaltsgesellschaft mbH Prinzregentenstrasse 22
80538 München / DE
Application number, filing date09727168.803.04.2009
[2011/07]
WO2009US02125
Priority number, dateUS20080123069P04.04.2008         Original published format: US 123069 P
[2011/07]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009123764
Date:08.10.2009
Language:EN
[2009/41]
Type: A2 Application without search report 
No.:EP2283133
Date:16.02.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 08.10.2009 takes the place of the publication of the European patent application.
[2011/07]
Search report(s)International search report - published on:EP11.02.2010
ClassificationIPC:C12N15/113, A61K31/713
[2014/32]
CPC:
C12N15/113 (EP,KR,US); A61K31/713 (EP,KR,US); A61K48/005 (KR);
A61P35/00 (EP); A61P35/04 (EP); C12N2310/122 (KR);
C12N2310/14 (EP,KR,US) (-)
Former IPC [2011/07]C12N15/11
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/07]
TitleGerman:ZUSAMMENSETZUNGEN UND VERWENDUNG VON EPAS1-INHIBITOREN[2011/07]
English:COMPOSITIONS AND USE OF EPAS1 INHIBITORS[2011/07]
French:COMPOSITIONS ET UTILISATION D'INHIBITEURS D'EPAS1[2011/07]
Entry into regional phase04.10.2010National basic fee paid 
04.10.2010Designation fee(s) paid 
04.10.2010Examination fee paid 
Examination procedure04.10.2010Examination requested  [2011/07]
24.01.2011Amendment by applicant (claims and/or description)
20.03.2013Despatch of a communication from the examining division (Time limit: M06)
30.09.2013Reply to a communication from the examining division
17.07.2014Communication of intention to grant the patent
28.11.2014Application deemed to be withdrawn, date of legal effect  [2015/23]
15.01.2015Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2015/23]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.03.2013
Fees paidRenewal fee
25.04.2011Renewal fee patent year 03
23.03.2012Renewal fee patent year 04
22.04.2013Renewal fee patent year 05
25.03.2014Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO2004076639  (WYETH CORP [US], et al);
 [Y]US2004220393  (WARD DONNA T [US], et al);
 [Y]WO2007055547  (KOREA RES INST OF BIOSCIENCE [KR], et al);
by applicantUS4426330
 US4534899
 WO8804300
 WO9011364
 US4987071
 US5013556
 US5093246
 US5108921
 WO9207065
 US5213804
 US5227170
 WO9315187
 US5264221
 WO9323569
 WO9402595
 US5334711
 US5354844
 US5356633
 US5395619
 US5416016
 US5417978
 US5459127
 US5462854
 US5469854
 US5512295
 US5521291
 US5527528
 US5534259
 US5542760
 US5543158
 US5543152
 US5547932
 US5556948
 US5580575
 US5583020
 US5591721
 US5595756
 US5627053
 WO9726270
 US5716824
 WO9810796
 WO9813526
 US5756353
 WO9831346
 US5854038
 US5858784
 WO9905094
 WO9904819
 WO9907409
 WO9914226
 WO9932619
 WO9954459
 US6001311
 US6013436
 WO0001846
 WO0027359
 US6071497
 WO0044895
 WO0044914
 US6110462
 WO0066604
 WO0066206
 US6180613
 WO0129058
 WO0136646
 WO0154664
 WO0160420
 US6294153
 WO0177350
 US6344194
 WO02053190
 WO02060412
 WO02066078
 US2002151523
 US6509323
 US2004063654
 US2004077595
 US2004087024
 US2004109888
 US2004166491
 WO2004076639
 US2004220393
 US7018609
 US2006135443
 US2006263435
 US7166302
 US2007031881
 US7217572
 WO2007055547
 US7427605
 US19980082404
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.